Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00084136
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Didanosine (enteric-coated);   Drug: Efavirenz;   Drug: Emtricitabine;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Lamivudine/Zidovudine

Indicates status has not been verified in more than two years